Literature DB >> 23801657

Stem cells as a good tool to investigate dysregulated biological systems in autism spectrum disorders.

Karina Griesi-Oliveira1, Daniele Yumi Sunaga, Lucas Alvizi, Estevão Vadasz, Maria Rita Passos-Bueno.   

Abstract

Identification of the causes of autism spectrum disorders (ASDs) is hampered by their genetic heterogeneity; however, the different genetic alterations leading to ASD seem to be implicated in the disturbance of common molecular pathways or biological processes. In this scenario, the search for differentially expressed genes (DEGs) between ASD patients and controls is a good alternative to identify the molecular etiology of such disorders. Here, we employed genome-wide expression analysis to compare the transcriptome of stem cells of human exfoliated deciduous teeth (SHEDs) of idiopathic autistic patients (n = 7) and control samples (n = 6). Nearly half of the 683 identified DEGs are expressed in the brain (P = 0.003), and a significant number of them are involved in mechanisms previously associated with ASD such as protein synthesis, cytoskeleton regulation, cellular adhesion and alternative splicing, which validate the use of SHEDs to disentangle the causes of autism. Autistic patients also presented overexpression of genes regulated by androgen receptor (AR), and AR itself, which in turn interacts with CHD8 (chromodomain helicase DNA binding protein 8), a gene recently shown to be associated with the cause of autism and found to be upregulated in some patients tested here. These data provide a rationale for the mechanisms through which CHD8 leads to these diseases. In summary, our results suggest that ASD share deregulated pathways and revealed that SHEDs represent an alternative cell source to be used in the understanding of the biological mechanisms involved in the etiology of ASD.
© 2013 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  CHD8; androgen signaling; expression studies; stem cells of human exfoliated deciduous teeth

Mesh:

Substances:

Year:  2013        PMID: 23801657     DOI: 10.1002/aur.1296

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  8 in total

Review 1.  The developmental transcriptome of the human brain: implications for neurodevelopmental disorders.

Authors:  Andrew T N Tebbenkamp; A Jeremy Willsey; Matthew W State; Nenad Sestan
Journal:  Curr Opin Neurol       Date:  2014-04       Impact factor: 5.710

2.  Altered mTORC1 signaling in multipotent stem cells from nearly 25% of patients with nonsyndromic autism spectrum disorders.

Authors:  A M Suzuki; K Griesi-Oliveira; C de Oliveira Freitas Machado; E Vadasz; E C Zachi; M R Passos-Bueno; A L Sertie
Journal:  Mol Psychiatry       Date:  2015-01-13       Impact factor: 15.992

3.  EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome.

Authors:  Emily E Miller; Gerson S Kobayashi; Camila M Musso; Miranda Allen; Felipe A A Ishiy; Luiz Carlos de Caires; Ernesto Goulart; Karina Griesi-Oliveira; Roseli M Zechi-Ceide; Antonio Richieri-Costa; Debora R Bertola; Maria Rita Passos-Bueno; Debra L Silver
Journal:  Hum Mol Genet       Date:  2017-06-15       Impact factor: 6.150

4.  Neurodevelopmental phenotype associated with CHD8-SUPT16H duplication.

Authors:  Thomas Smol; Caroline Thuillier; Elise Boudry-Labis; Anne Dieux-Coeslier; Bénédicte Duban-Bedu; Roseline Caumes; Sonia Bouquillon; Sylvie Manouvrier-Hanu; Catherine Roche-Lestienne; Jamal Ghoumid
Journal:  Neurogenetics       Date:  2019-12-10       Impact factor: 2.660

5.  Investigation of 15q11-q13, 16p11.2 and 22q13 CNVs in autism spectrum disorder Brazilian individuals with and without epilepsy.

Authors:  Danielle P Moreira; Karina Griesi-Oliveira; Ana L Bossolani-Martins; Naila C V Lourenço; Vanessa N O Takahashi; Kátia M da Rocha; Eloisa S Moreira; Estevão Vadasz; Joanna Goes Castro Meira; Debora Bertola; Eoghan O'Halloran; Tiago R Magalhães; Agnes C Fett-Conte; Maria Rita Passos-Bueno
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

6.  Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.

Authors:  K Griesi-Oliveira; A Acab; A R Gupta; D Y Sunaga; T Chailangkarn; X Nicol; Y Nunez; M F Walker; J D Murdoch; S J Sanders; T V Fernandez; W Ji; R P Lifton; E Vadasz; A Dietrich; D Pradhan; H Song; G-L Ming; X Gu; G Haddad; M C N Marchetto; N Spitzer; M R Passos-Bueno; M W State; A R Muotri
Journal:  Mol Psychiatry       Date:  2014-11-11       Impact factor: 15.992

Review 7.  Stem cell therapy in autism: recent insights.

Authors:  Dario Siniscalco; Suresh Kannan; Neomar Semprún-Hernández; Adrien A Eshraghi; Anna Lisa Brigida; Nicola Antonucci
Journal:  Stem Cells Cloning       Date:  2018-10-23

8.  Actin cytoskeleton dynamics in stem cells from autistic individuals.

Authors:  Karina Griesi-Oliveira; Angela May Suzuki; Aline Yasuda Alves; Ana Carolina Cintra Nunes Mafra; Guilherme Lopes Yamamoto; Suzana Ezquina; Yuli Thamires Magalhães; Fabio Luis Forti; Andrea Laurato Sertie; Elaine Cristina Zachi; Estevão Vadasz; Maria Rita Passos-Bueno
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.